专注于亚洲人群强直临床研究,将强直诊疗理念覆盖全国

共享全球
专业智慧

健康热线:

021-54850088
医院概况 Hospital Overview >

上海强直医院——打造强直性脊柱炎品牌医院

021-54850088
视频聚焦
领导评价 Leader evaluation
  • <
  • >
中华中医药学会秘书长李俊德评价
国家卫生部原副部长孙隆椿评价
医生风采 Expert style
  • <
  • >
任鸿军:只要你将希望托付,我必会全力以赴
陈付彩:大医精诚,仁德为先
汪平平:信任的力量
《走进医师》吴书斌:致力攻克“不死的癌症”
任鸿军谈设备支持在AS诊疗中的意义
吴书斌谈多学科联合治疗在AS领域的运用
陈付彩谈多学科联合治疗在AS临床诊疗中的意义
热点聚焦 Hot focus
  • <
  • >
上海生活时尚频道:建党96周年七一党课宣教日
上海新闻综合:全国强直性脊柱炎贫困援助专项基金
上海新闻综合:第三届京沪多学科专家联合会诊
强直科普 Strong science
  • <
  • >
【强直性脊柱炎复健功能操 】
【强直治疗如何用药1片抵3片 】
【强直患者为何会出现早上背直晚上背驼?】
【强直患者为何晚上痛到睡不着】
【强直性脊柱炎40岁之后是否就不再发展了】
【炎炎夏日如何防止强直病情加重】
【强直性脊柱炎康复操之髋部功能锻炼】
【强直性脊柱炎患者为何会出现驼背、脊柱畸形?】
【强直性脊柱炎为何病情反复且一次比一次疼】
【AS讲堂一】
【AS讲堂二】
【AS讲堂三】
【AS讲堂四】
联合看诊
推荐医生 Recommended experts
便民服务
在线问诊 Online inquiry
预约挂号Online BOOKING
 男    女
已有8533人挂号,已有7381人咨询

强直性脊柱炎患者死亡相关因素有经济、合并症和髋关节置换术

  • 来源:上海强直医院
  • 阅读量:
如果您有什么问题,随时在线咨询!或者拨打免费咨询热线:021-64055288

 

 

 

作者:Exarchou S, et al.

翻译:北京大学首钢医院 丁艳(ding820626@163.com)

审校: 王宽婷

摘要:目的: 目前关于强直性脊柱炎死亡率的研究很少。因此,本研究旨在评估:(1)强直性脊柱炎患者和普通人群的死亡率比较;(2)强直性脊柱炎患者死亡的影响因素。
方法: 来自全国疾病登记数据库的风湿科或内科门诊所诊断的强直性脊柱炎患者(n = 8600)为研究对象,来自于人口普查登记的一般人群为对照组(N = 40460),对照组与强直性脊柱炎患者的年龄、性别及地区相匹配。随访期限从2006年1月1日或疾病初次诊断开始,随访终点为死亡、移民或2012年12月31日。从疾病登记资料中的获取患者的社会经济因素、临床表现、关节手术、并发症和治疗药物。用Cox回归模型来确定强直性脊柱炎患者的死亡率和死亡影响因素。
结果: 强直性脊柱炎患者中有496例死亡,对症组中有1533例死亡。年龄和性别调整后的HR为1.60(95% CI 1.44至1.77),男性(年龄调整后的HR = 1.53,95% CI 1.36至1.72)和女性(年龄调整后的HR = 1.83,95% CI 1.50至2.22)患者的死亡率均增加。在强直性脊柱炎组,与死亡率相关的因素包括教育水平较低、常见的合并症(糖尿病、感染、心血管疾病、肺部疾病和恶性肿瘤)和髋关节置换手术。

结论:强直性脊柱炎患者中男性和女性患者的死亡率均增加。与死亡相关

的因素包括社会经济因素、常见的合并症和髋关节置换手术。

附原文:Objectives Information on mortality in ankylosing spondylitis (AS) is scarce. Our study therefore aimed to assess: (1) mortality in AS versus the general population, and (2) predictors of death in the AS population.Methods Nationwide cohorts of patients with AS diagnosed at rheumatology or internal medicine outpatient clinics (n=8600) and age-matched, sex-matched and county-matched general population comparators (n=40 460) were identified from the National Patient Register and the census register, respectively. The follow-up period began on 1 January 2006 or at the first date of registered diagnosis thereafter and extended until death, emigration or 31 December 2012, whichever occurred first. Socioeconomic variables, AS-related clinical manifestations, joint surgery, comorbidities and medication were identified from other national registers. Cox regression models were used to determine mortality and predictors for death in the AS cohort. Results There were 496 deaths in the AS cohort and 1533 deaths in the control cohort resulting in an age-adjusted and sex-adjusted HR of 1.60 (95% CI 1.44 to 1.77), with increased mortality for men (age-adjusted HR=1.53, 95% CI 1.36 to 1.72) and women (ageadjusted HR=1.83, 95% CI 1.50 to 2.22). Within the AS cohort, statistically significant predictors for death were a lower level of education, general comorbidities (diabetes, infections, cardiovascular, pulmonary and malignant diseases) and previous hip replacement surgery. Conclusions Mortality was increased for male and female patients with AS. Predictors of death within the AS cohort included socioeconomic status, general comorbidities and hip replacement surgery.
引自:Exarchou S, et al. Mortality in ankylosing spondylitis: results from a nationwide population-based study . Ann Rheum Dis 2016;75:1466–1472